Michael Yee, Jefferies senior biotech analyst, joins 'Squawk Box' to discuss news of Eli Lilly's launch of 'LillyDirect', an online direct-to-consumer pharmacy where patients can get the company's obesity, diabetes and migraine medications sent to their home with a doctor's prescription, the impact on patients and investors, and more.
